Laparoscopic surgery for rectal cancer: short-term benefits and oncologic outcomes using more than one technique.
BACKGROUND
Several minimally invasive techniques have now been described for rectal cancer resection. Current outcome data for these approaches from high volume, single institutions remain limited. Our aim was to review outcomes in patients undergoing minimally invasive surgery for rectal cancer at our institution in the current era.


METHODS
A retrospective analysis was done to assess short-term benefits and oncologic outcomes in patients undergoing minimally invasive surgery for rectal cancer between 2004 and 2007.


RESULTS
One-hundred consecutive patients (61 men, median age 62) with a median follow-up of 1.8 years were identified. Sixty-seven had hand-assisted laparoscopic surgery (HALS), while 33 were done laparoscopic-assisted (LA). Seventy-two patients underwent anterior resection, 27 an abdominal perineal resection, and 1 a total proctocolectomy. Tumor stage was stage 1 (21%), stage 2 (17%), stage 3 (56%), and stage 4 (6%). A median of 16 lymph nodes, a median 3.4 cm distal margin, and a 99% negative circumferential margin was achieved. The 3-year disease-free and overall survivals were 86.2 and 94.5%, respectively. Three cases required conversion. Median time to both diet and first bowel movement was 3 days, and median length of stay was 5 days. Length of stay, time to soft diet, incision length, and pain scores were less using a LA approach compared to HALS (P < 0.01). Overall morbidity was 26% with no mortality.


CONCLUSIONS
Both minimally invasive techniques used achieved excellent oncologic results in patients with rectal cancer. The LA approach had slightly better short-term outcomes.
Larson
D W
DW
Mayo Clinic Rochester, Mayo Clinic College of Medicine, Rochester, MN, USA. larson.david2@mayo.edu
Boostrom
S Y
SY
Cima
R R
RR
Pemberton
J H
JH
Larson
D R
DR
Dozois
E J
EJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D006760:Hospitalization; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012004:Rectal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
Ann Surg Oncol. 2009 Jun;16(6):1480-7
19290486
Surg Endosc. 2005 Nov;19(11):1460-7
16206013
Surg Endosc. 2004 Aug;18(8):1211-5
15457380
N Engl J Med. 2004 May 13;350(20):2050-9
15141043
J Am Coll Surg. 2007 Feb;204(2):291-307
17254934
Surg Endosc. 2006 Aug;20(8):1197-202
16865622
Ann Surg. 1998 Jun;227(6):800-11
9637543
Br J Surg. 2007 Dec;94(12):1555-61
17668915
Ann Surg. 2009 Jul;250(1):54-61
19561481
Lancet. 2005 May 14-20;365(9472):1718-26
15894098
Int J Colorectal Dis. 2007 Apr;22(4):367-72
16786316
J Clin Oncol. 2005 Dec 1;23(34):8664-70
16260700
Dis Colon Rectum. 1999 Jul;42(7):930-9
10411441
Surg Endosc. 2004 Feb;18(2):281-9
14691716
Dis Colon Rectum. 2007 Apr;50(4):464-71
17195085
Dig Surg. 2007;24(5):367-74
17785982
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432
18425886
J Clin Oncol. 2007 Jul 20;25(21):3061-8
17634484
Ann Surg. 2005 Dec;242(6):890-5, discussion 895-6
16327499
Lancet Oncol. 2005 Jul;6(7):477-84
15992696
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005200
17054246
Ann Surg Oncol. 2006 Mar;13(3):413-24
16450220
Dis Colon Rectum. 2007 Dec;50(12):2047-53
17906896
Ann Surg. 2007 Oct;246(4):655-62; discussion 662-4
17893502
ANZ J Surg. 2007 Jul;77(7):508-16
17610681